Vanguard Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.46M | Buy |
6,662,063
+1,691,809
| +34% | +$2.4M | ﹤0.01% | 2933 |
|
|
2025
Q1 | $7.6M | Buy |
4,970,254
+644,991
| +15% | +$987K | ﹤0.01% | 2993 |
|
|
2024
Q4 | $10.7M | Sell |
4,325,263
-360,235
| -8% | -$893K | ﹤0.01% | 2915 |
|
|
2024
Q3 | $5.39M | Sell |
4,685,498
-2,053
| -0% | -$2.36K | ﹤0.01% | 3246 |
|
|
2024
Q2 | $5.16M | Sell |
4,687,551
-242,224
| -5% | -$266K | ﹤0.01% | 3249 |
|
|
2024
Q1 | $6.11M | Buy |
4,929,775
+207,418
| +4% | +$257K | ﹤0.01% | 3217 |
|
|
2023
Q4 | $4.96M | Buy |
4,722,357
+1,359,311
| +40% | +$1.43M | ﹤0.01% | 3295 |
|
|
2023
Q3 | $23M | Buy |
3,363,046
+33,482
| +1% | +$229K | ﹤0.01% | 2492 |
|
|
2023
Q2 | $34.5M | Buy |
3,329,564
+137,138
| +4% | +$1.42M | ﹤0.01% | 2356 |
|
|
2023
Q1 | $25.8M | Buy |
3,192,426
+70,171
| +2% | +$568K | ﹤0.01% | 2479 |
|
|
2022
Q4 | $49.2M | Buy |
3,122,255
+190,546
| +6% | +$3M | ﹤0.01% | 2197 |
|
|
2022
Q3 | $46.1M | Buy |
2,931,709
+118,024
| +4% | +$1.86M | ﹤0.01% | 2224 |
|
|
2022
Q2 | $39.3M | Buy |
2,813,685
+84,865
| +3% | +$1.18M | ﹤0.01% | 2307 |
|
|
2022
Q1 | $47M | Buy |
2,728,820
+10,713
| +0.4% | +$185K | ﹤0.01% | 2336 |
|
|
2021
Q4 | $39.5M | Buy |
2,718,107
+39,167
| +1% | +$569K | ﹤0.01% | 2484 |
|
|
2021
Q3 | $48.2M | Buy |
2,678,940
+112,169
| +4% | +$2.02M | ﹤0.01% | 2379 |
|
|
2021
Q2 | $45.1M | Buy |
2,566,771
+448,919
| +21% | +$7.88M | ﹤0.01% | 2436 |
|
|
2021
Q1 | $53.4M | Buy |
2,117,852
+630,711
| +42% | +$15.9M | ﹤0.01% | 2278 |
|
|
2020
Q4 | $9.62M | Buy |
1,487,141
+185,983
| +14% | +$1.2M | ﹤0.01% | 3014 |
|
|
2020
Q3 | $3.34M | Hold |
1,301,158
| – | – | ﹤0.01% | 3331 |
|
|
2020
Q2 | $2.11M | Sell |
1,301,158
-99,591
| -7% | -$161K | ﹤0.01% | 3414 |
|
|
2020
Q1 | $1.46M | Sell |
1,400,749
-11,184
| -0.8% | -$11.6K | ﹤0.01% | 3383 |
|
|
2019
Q4 | $2.67M | Buy |
1,411,933
+36,090
| +3% | +$68.2K | ﹤0.01% | 3360 |
|
|
2019
Q3 | $1.49M | Sell |
1,375,843
-491,995
| -26% | -$531K | ﹤0.01% | 3541 |
|
|
2019
Q2 | $4.09M | Buy |
1,867,838
+30,191
| +2% | +$66.1K | ﹤0.01% | 3236 |
|
|
2019
Q1 | $11M | Buy |
1,837,647
+1,116,785
| +155% | +$6.69M | ﹤0.01% | 2769 |
|
|
2018
Q4 | $5.33M | Sell |
720,862
-468,312
| -39% | -$3.46M | ﹤0.01% | 3063 |
|
|
2018
Q3 | $17.3M | Sell |
1,189,174
-7,669
| -0.6% | -$111K | ﹤0.01% | 2648 |
|
|
2018
Q2 | $23.9M | Buy |
1,196,843
+29,414
| +3% | +$587K | ﹤0.01% | 2490 |
|
|
2018
Q1 | $20.5M | Buy |
1,167,429
+41,059
| +4% | +$719K | ﹤0.01% | 2490 |
|
|
2017
Q4 | $27.8M | Sell |
1,126,370
-57,504
| -5% | -$1.42M | ﹤0.01% | 2356 |
|
|
2017
Q3 | $30.6M | Buy |
1,183,874
+371,556
| +46% | +$9.59M | ﹤0.01% | 2296 |
|
|
2017
Q2 | $22M | Buy |
812,318
+100,799
| +14% | +$2.73M | ﹤0.01% | 2409 |
|
|
2017
Q1 | $21.2M | Buy |
711,519
+106,303
| +18% | +$3.17M | ﹤0.01% | 2417 |
|
|
2016
Q4 | $16.4M | Buy |
605,216
+179,729
| +42% | +$4.88M | ﹤0.01% | 2509 |
|
|
2016
Q3 | $10.9M | Buy |
425,487
+6,303
| +2% | +$161K | ﹤0.01% | 2648 |
|
|
2016
Q2 | $7.74M | Buy |
419,184
+249,888
| +148% | +$4.62M | ﹤0.01% | 2771 |
|
|
2016
Q1 | $3.21M | Buy |
169,296
+19,308
| +13% | +$366K | ﹤0.01% | 3183 |
|
|
2015
Q4 | $4.04M | Buy |
+149,988
| New | +$4.04M | ﹤0.01% | 3082 |
|